Seminars in Thrombosis and Hemostasis

Article	Citations
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis	76
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization	73
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis	53
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?	43
Thrombin: A Pivotal Player in Hemostasis and Beyond	42
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis	34
The Role of Fibrin(ogen) in Wound Healing and Infection Control	32
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	31
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	31
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature	30
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx	30
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease	27
Mean Platelet Volume Predicts Severe COVID-19 Illness	24
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan	22
The Role of Red Blood Cells in Hemostasis	22
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	21
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage	21
Platelet Activation and Thrombosis in COVID-19	21
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis	20
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	20
Snake Venoms in Diagnostic Hemostasis and Thrombosis	20
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study	20
Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study	19
The More Recent History of Hemophilia Treatment	19
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations	19

Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review	19
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	19
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series	19
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature	18
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19	18
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study	18
Advances in the Management of Cancer-Associated Thrombosis	18
Fibrinolysis in Patients with Liver Disease	17
Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review	17
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis	17
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness	17
Platelet Function in Viral Immunity and SARS-CoV-2 Infection	17
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II	16
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis	16
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review	16
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis	15
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives	15
Solid Phase Assays for Antiphospholipid Antibodies	15
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III	15
Fibrinolysis in Acute and Chronic Cardiovascular Disease	14
Testing for Lupus Anticoagulants	14
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians	14
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches	14
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	14
Thrombin Generation in Patients with Coronavirus Disease 2019	14
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	13
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review	13
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	13
Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets	13
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data	13
Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis	13
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19	13
Platelet Function Testing: Update and Future Directions	13
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	12
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism	12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	12
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part I	12
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	12
Gene Therapy for Inherited Bleeding Disorders	12
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation	12
Current Challenges in the Peripartum Management of Women with von Willebrand Disease	12
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years	12
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	11
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	11
The Art and Science of Building a Computational Model to Understand Hemostasis	11
ROTEM Testing for Direct Oral Anticoagulants	11
The Biological Significance of von Willebrand Factor O-Linked Glycosylation	11
Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism	11
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review	11
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II	11

Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment	11
Impaired Fibrinolysis in the Antiphospholipid Syndrome	11
Mechanisms of Bone Remodeling Disorder in Hemophilia	11
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies	11
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives	11
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	11
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment	10
Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations	10
Venous Thromboembolism among Critically Ill Children: A Narrative Review	10
Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized Controlled Trials	10
One Hundred Years of Congenital Fibrinogen Disorders	10
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV	10
Fibrinolysis in Venous Thromboembolism	10
Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial	10
The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review	10
Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?	10
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review	10
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19	9
Cancer-Associated Splanchnic Vein Thrombosis	9
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation	9
Altered Fibrinolysis during and after Surgery	9
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms	9
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger	9
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review	9
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan	9
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond	9
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia	9
Heparin: The Journey from Parenteral Agent to Nasal Delivery	9
Right Atrial Thrombosis and Pulmonary Embolism: A Narrative Review	8
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties	8
Cerebral Venous Thrombosis	8
The Current Role of Platelet Function Testing in Clinical Practice	8
2021 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	8
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding	8
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	8
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders	8
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	8
Heparan Sulfate Proteoglycans in Diabetes	8
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	8
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	8
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	8
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	8
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients	8
Viscoelastic Testing in the Management of Adult Patients on Mechanical Circulatory Support Devices with Focus on Extracorporeal Membrane Oxygenation	8
Altered Fibrinolysis in Hematological Malignances	8
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	8
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study	7
The Role of Epigenetics in the Regulation of Hemostatic Balance	7
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding—A Systematic Review and a Cohort Study	7
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?	7
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19)	7
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	7
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention	7
The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review	7
Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review	7
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	7
Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter—A Systematic Review and Meta-analysis	7
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	7
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review	7
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	7
Clot Waveform Analysis for Monitoring Hemostasis	7
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology	7
Thrombin Generation Markers as Predictors of Cancer-Associated Venous Thromboembolism: A Systematic Review	7
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	7
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	7
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	7
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition	7
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche	6
Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review	6
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly	6
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	6
Planning Pregnancy and Birth in Women with Inherited Bleeding Disorders	6
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates	6
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients	6
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States	6
New-Onset Atrial Fibrillation and Adverse In-Hospital Outcome in Patients with Acute Pulmonary Embolism	6
Toward 50 Years of Seminars in Thrombosis and Hemostasis	6
Impact of Thrombosis and Bleeding in Patients with Severe COVID-19 versus Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation	6
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease	6
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	6

Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	6
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	6
Modified Thromboelastography for Peri-interventional Assessment of Platelet Function in Cardiology Patients: A Narrative Review	6
Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant	6
Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis	6
Fifty Years of Fibrinogen Structure and Function	6
Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography	6
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis	6
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions	6
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy	5
Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19)	5
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?	5
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	5
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	5
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study	5
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	5
Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation	5
Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals	5
The Most Highly Cited Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 50 Years in the Making	5
Colchicine as a Modulator of Platelet Function: A Systematic Review	5
Von Willebrand Factor Multimer Analysis and Classification: A Comprehensive Review and Updates	5
Prognostic Impact of the International Society on Thrombosis and Hemostasis Disseminated Intravascular Coagulation Score in Sepsis: A Systematic Review	5
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	5
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies	5
What Role Does Microthrombosis Play in Long COVID?	5
New STH (2020) Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	5
Next-Generation Sequencing and Emerging Technologies*	5
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	5
Tranexamic Acid Treatment for Trauma Victims	5
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence	5
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	5
Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience	5
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)	5
The Role of the von Willebrand Factor Collagen-Binding Assay (VWF:CB) in the Diagnosis and Treatment of von Willebrand Disease (VWD) and Way Beyond: A Comprehensive 36-Year History	5
Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders	5
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	5
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review	5
Platelet Parameters as Biomarkers for Thrombosis Risk in Cancer: A Systematic Review and Meta-analysis	5
Evolution of Antiphospholipid Syndrome	5
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	5
Septic Pulmonary Embolism: A Contemporary Profile	4
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	4
Research Trends in Anticoagulation Therapy over the Last 25 Years	4
Description of an In Vitro Platelet Function Analyzer (PFA-100/PFA-200) 30 Years in the Making	4
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	4
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients	4
Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients	4
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	4
Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia	4
A Historical Perspective on the Reversal of Anticoagulants	4
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	4
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	4
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	4
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	4
Laboratory Approaches to Test the Function of Antiphospholipid Antibodies	4
Does COVID-19 Provide a Clue for Thrombosis in ITP?	4
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness	4
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	4
The History of Factor XIII Deficiency	4
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	4
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients	4
Hemostasis in Neonates with Perinatal Hypoxia—Laboratory Approach: A Systematic Review	4
Lupus Anticoagulant and Cardiopulmonary Bypass	4
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	4
Fibrinolysis and Remote Ischemic Conditioning: Mechanisms and Treatment Perspectives in Stroke	4
Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease	4
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans	4
Factor XII Structure–Function Relationships	4
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	4
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application	4
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	4
Crucial Stepping Stones in Platelet History	3
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	3
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	3
A Critical Reappraisal of the Bleeding Time	3
Recent Advances in Thrombosis and Hemostasis—Part VII	3
Early Resolution of Heyde's Syndrome following Transcatheter Aortic Valve Replacement	3
Trousseau's Syndrome in 19th Century Qing Dynasty Paintings of Breast Tumors: Early Insights into Cancer and Thrombosis Risk	3
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	3
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers	3
Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome—Single Centre Observational Study in the United Kingdom	3
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	3
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	3
Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part I	3
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	3
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System	3
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	3
New Insights in Coagulation and Fibrinolysis in Patients with Primary Brain Cancer: A Systematic Review	3
Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges	3
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	3
The Role of Myeloid Cells in Thromboinflammatory Disease	3
New Seminars in Thrombosis and Hemostasis 2022 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	3
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology	3
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	3
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease	3